Egoo.Health is a Denmark-based startup that provides a platform for biomarker measurement and self-testing. Founded in 2019, the company offers a range of advanced self-testing capsules, including PHE, SARS/INFLU A+B, CRP, and SARS-Cov-2, enabling individuals to effortlessly monitor their biomarker levels daily. This eliminates the need for frequent visits to healthcare professionals, making biomarker tracking more convenient. Egoo.Health recently secured a kr5.00M Seed Round investment on 06 August 2019, with funding from PreSeed Ventures and KMD Venture. With a focus on Health Care, Information Technology, and Medical Devices, Egoo.Health is positioned to innovate and disrupt the healthcare industry with its advanced self-testing solutions.
No recent news or press coverage available for Egoo.Health.